Core Viewpoint - The children's dietary supplement market is rapidly growing, with agebox's product, Akif, gaining significant attention due to its unique positioning and effective formulation aimed at enhancing growth and development [1] Group 1: Product Overview - Akif focuses on the "GH-IGF-1 axis" and utilizes a unique "IGF-1 sensitizer" to differentiate itself in the market [1] - Since its entry into the Chinese market at the end of 2022, Akif has attracted over 50,000 child users with a remarkable repurchase rate of 70% [1] Group 2: Ingredients and Research - Akif's main components are pure natural plant and animal extracts, including oyster essence, astragalus extract, South African hookworm extract, and Eurycoma longifolia extract, which are believed to promote growth and enhance immunity [2] - The company agebox has been in this field for over a decade, utilizing an advanced drug screening platform to maximize the health potential of various natural extracts [3] Group 3: Research and Development Process - The PDD drug screening platform established by agebox in the U.S. in 2009 focuses on complex health issues and creates biological data maps to support the development of effective formulations [5] - Akif's development process emphasizes three main aspects: precise selection of ingredients, deep purification using advanced extraction techniques, and scientific formulation and validation through rigorous testing [6][8] Group 4: Safety and Efficacy - Akif adheres to evidence-based medicine principles, having undergone extensive testing, including cell and animal experiments, with over 50,000 real users and ongoing clinical studies with top children's hospitals in China [9][11] - The product meets the U.S. FDA GRAS standards and has passed multiple safety certifications, indicating a high level of safety and efficacy [10] Group 5: Market Position and Future Outlook - Akif has shown a significant improvement in annual growth rates among children using the product, with an average increase of 2.59 cm/year and a ΔHtSDS of 0.46 [11] - The innovative approach and rigorous scientific backing of Akif position it as a leading product in the children's health supplement market, encouraging consumer trust and patience for further advancements in the industry [12]